Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=340&ordering=end_planned
{ "count": 2244, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=360&ordering=end_planned", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=320&ordering=end_planned", "results": [ { "id": 2522, "title": { "de": "Semiautomatische Vermessung von CT-Datensätzen nach Augmentation des Sinus maxillaris zur Ermittlung der Veränderung des Augmentatvolumens in Abhängigkeit von der Zeit.", "en": "Semiautomatische Vermessung von CT-Datensätzen nach Augmentation des Sinus maxillaris zur Ermittlung der Veränderung des Augmentatvolumens in Abhängigkeit von der Zeit." }, "short": "Volumetrie in vivo", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-05-01T02:00:00+02:00", "begin_effective": "2011-07-01T02:00:00+02:00", "end_planned": "2012-06-01T02:00:00+02:00", "end_effective": "2015-06-30T02:00:00+02:00", "assignment": "2011-07-06T15:12:29+02:00", "program": null, "subprogram": null, "organization": 14111, "category": 10, "type": 10, "partner_function": 4, "manager": 58106, "contact": 58106, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2522-58106-10" ] }, { "id": 2394, "title": { "de": "CXCL13 Chemokin als neuer Biomarker bei systemischer Sklerodermie", "en": "CXCL13 Chemokine - a putative biomarker in systemic sclerosis" }, "short": "CXCL13 bei Sklerodermie", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-01-01T01:00:00+01:00", "begin_effective": "2011-04-01T02:00:00+02:00", "end_planned": "2012-06-01T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2011-02-04T11:58:45+01:00", "program": 79, "subprogram": null, "organization": 14047, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2480, "title": { "de": "FET FlagShip: Information Technology Future of Medicine", "en": "FET FlagShip: Information Technology Future of Medicine" }, "short": "IT FoM", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-05-01T02:00:00+02:00", "begin_effective": "2011-05-01T02:00:00+02:00", "end_planned": "2012-06-01T02:00:00+02:00", "end_effective": "2012-04-30T02:00:00+02:00", "assignment": "2011-05-19T10:22:48+02:00", "program": 24, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": 51663, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": " 285609", "ethics_committee": null, "edudract_number": null, "persons": [ "2480-51663-10" ] }, { "id": 2921, "title": { "de": "NANOFAT Neue Hoffnung im Kampf gegen Adipositas: MicroRNA Drug Delivery für die Steigerung der Fettverbrennung im Fettgewebe", "en": "NANOFAT MicroRNA Drug Delivery as basis for increased fat burn in the adipose tissue" }, "short": "NANOFAT", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-05-01T02:00:00+02:00", "begin_effective": "2011-08-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2012-07-23T12:53:58+02:00", "program": null, "subprogram": "Human Technology Interface (HTI)", "organization": 14028, "category": 10, "type": 10, "partner_function": 2, "manager": 52854, "contact": 52854, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2921-52854-10" ] }, { "id": 2521, "title": { "de": "NEUE WIRKSTOFFE ZUR THERAPIE GASTROENTEROPANKREATISCHER TUMOREN (CARCINOIDS)", "en": "NOVEL AGENTS FOR THERAPY OF GASTROENTEROPANCREATIC TUMORS (CARCINOIDS)" }, "short": "CARCINOID THERAPY", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-07-01T02:00:00+02:00", "begin_effective": "2011-07-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-06-30T02:00:00+02:00", "assignment": "2011-07-06T10:24:22+02:00", "program": null, "subprogram": "Stadt Graz Kulturamt - Wissenschaft", "organization": 14014, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2386, "title": { "de": "Europäisches Forschungs-Ethikkommissions-Netzwerk", "en": "European Research Ethics Committees Network" }, "short": "EURECNET", "url": "http://www.eurecnet.org/index.html", "abstract": { "de": null, "en": "EURECNET is a network that brings together national REC associations, networks or comparable initiatives but also other bodies relevant in the field of research involving human participants like National Ethics Councils and the European Commission's ethical review system. Such a network forms the infrastructural basis to promote awareness of specific working practices of RECs across Europe, to enhance the shared knowledge base of European RECs, to support coherent reviews and opinions and to meet new challenges and emerging ethical issues. The central objective of EURECNET as a Coordinating Action is to foster the already existing network of European REC networks (in short 'EUREC').\r\n\r\nIn particular, the contribution of EURECNET aims at five different levels:\r\n- fostering a sustainable infrastructure for European RECs (including a statute and a secretariat) to promote exchange and cooperation and to allow for international cooperation;\r\n- gathering information on RECs in Europe to build a basis for mutual exchange - collecting and evaluating training materials for REC members to enhance the quality of review;\r\n- conducting capacity building to facilitate the development of national REC networks (as future partners of EUREC);\r\n- identifying emerging ethical issues to develop common solutions for challenges posed by new technologies and scientific methodologies." }, "begin_planned": "2009-07-01T02:00:00+02:00", "begin_effective": "2011-03-01T01:00:00+01:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2014-08-31T02:00:00+02:00", "assignment": "2011-01-31T12:01:32+01:00", "program": 24, "subprogram": "Area: 5.1.1.2 Research on Ethics in science and technology\r\nTopic: SiS-2009-1.1.2.2 Networking and capacity-building activities to support ethics committees:", "organization": 14038, "category": 10, "type": 10, "partner_function": 2, "manager": 51627, "contact": 51627, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "244519", "ethics_committee": null, "edudract_number": null, "persons": [ "2386-51627-10" ] }, { "id": 2620, "title": { "de": "Etablierung des Mutationsspektrums in zirkulierenden Tumorzellen von Patienntinnen und Patienten mit Mamma- oder Prostatakarzinomen _ONCOTYROL", "en": "Establishment of the mutation spectrum in circulating tumor cells of patients with breast and prostate cancer" }, "short": "ONCOTYROL", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-09-01T02:00:00+02:00", "begin_effective": "2010-09-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-06-30T02:00:00+02:00", "assignment": "2011-10-28T13:07:04+02:00", "program": 94, "subprogram": "Das K1 Zentrum ONCOTYROL - Center for Personalized Cancer Medicine ist im Rahmen des vom BMWA und BMVIT initiierten Strukturprogramms COMET in Zusammenarbeit mit\r\n\r\n * Land Tirol\r\n * Land Steiermark (Abteilung 3, Abteilung 14 und Wirtschaftsressort)\r\n * Steirische Wirtschaftsförderung\r\n * den drei regionalen Universitäten und der Industrie geschaffen worden.", "organization": 14021, "category": 10, "type": 10, "partner_function": 1, "manager": null, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2, 416, 1040, 1154 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2257, "title": { "de": "Einfluss unterschiedlicher Lichtspektren am Arbeitsplatz auf Physiologie und circadiane Rhythmik", "en": "Physiological and circadian effects of light in the work-place" }, "short": "Wirkung von Licht am Arbeitsplatz", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-07-01T02:00:00+02:00", "begin_effective": "2010-08-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2010-07-29T12:08:13+02:00", "program": 79, "subprogram": "Interdisziplinäre Humanmedizin", "organization": 14010, "category": 10, "type": 10, "partner_function": 4, "manager": 51671, "contact": 51671, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": "13891", "ethics_committee": null, "edudract_number": null, "persons": [ "2257-51671-10" ] }, { "id": 4261, "title": { "de": "TRPC\u2029 modulation \u2029by \u2029PKG\u2029 and \u2029Muscular \u2029Dystrophy", "en": "TRPC\u2029 modulation \u2029by \u2029PKG\u2029 and \u2029Muscular \u2029Dystrophy" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-01-01T01:00:00+01:00", "begin_effective": "2011-04-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2016-02-01T10:37:22+01:00", "program": 101, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 58906, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 15 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "4261-58906-10" ] }, { "id": 1992, "title": { "de": "Laserakupunktur als unterstützende Therapie beim Neugeborenen mit Entzugssyndrom aufgrund mütterlicher Substitutionstherapie", "en": "Laserakupunktur als unterstützende Therapie beim Neugeborenen mit Entzugssyndrom aufgrund mütterlicher Substitutionstherapie" }, "short": "LASERAKUP_NEUGEB_ENTZUG", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2009-07-01T02:00:00+02:00", "begin_effective": "2009-07-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-06-30T02:00:00+02:00", "assignment": "2009-11-26T15:43:39+01:00", "program": null, "subprogram": null, "organization": 14094, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2309, "title": { "de": "TRPA1 als Biomarker für Chemikalienunverträglichkeit", "en": "TRPA1 as biomarker of multiple chemical sensitivity" }, "short": "TRPA_BIOMARKER_CHEMIKALIEN", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-07-01T02:00:00+02:00", "begin_effective": "2010-10-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2010-09-22T18:13:45+02:00", "program": null, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 51529, "contact": 51529, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2309-51529-10" ] }, { "id": 2635, "title": { "de": "Innovative Sensorik zur Quantifizierung kardialer Regelungsmechanismen bei Herzinsuffizienz (HI-Sens)", "en": "Innovative sensorics to quantify cardiac regulation in heart failure (HI-Sens)" }, "short": "HI-Sens", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-07-01T02:00:00+02:00", "begin_effective": "2011-11-01T01:00:00+01:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2013-03-31T01:00:00+01:00", "assignment": "2011-11-15T11:13:18+01:00", "program": null, "subprogram": "Human Technology Interface", "organization": 14083, "category": 10, "type": 10, "partner_function": 2, "manager": 51700, "contact": 51700, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2635-51700-10" ] }, { "id": 2872, "title": { "de": "Chordom - Charakterisierung der MUG-Chor1 Zelllinie", "en": "Chordoma - Characterizing MUG-Chor1 cell line" }, "short": "Chordoma", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-04-01T02:00:00+02:00", "begin_effective": "2012-04-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-06-30T02:00:00+02:00", "assignment": "2012-05-24T12:00:53+02:00", "program": null, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 4, "manager": 54171, "contact": 54171, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 530 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2872-54171-10" ] }, { "id": 2363, "title": { "de": "Detektion der BRAF V600E Mutation in Lentigo Maligna Melanoma", "en": "Detection of the BRAF V600E mutation in Lentigo Maligna Melanoma lesions" }, "short": "BRAF V600E", "url": null, "abstract": { "de": "Das maligne Melanom (MM) gilt als eine der aggressivsten Formen von Hautkrebs mit einer hohen\r\nSterblichkeitsrate und oftmals inadäquaten Therapiemöglichkeiten, insbesondere bei\r\nMetastasierung. Die Voraussetzungen für die Gabe neuer, vielversprechender Therapien sind die\r\npräzise Diagnose und das Wissen über den Mutationsstatus des Tumors.\r\nDie Diagnose der Lentigo maligna melanoma (LMM), einer Sonderform des MM, wird durch klinische\r\nund histopathologische Ähnlichkeiten mit pigmentierter aktinischer Keratose (in situ\r\nPlattenepithelkarzinom) und solarer Lentigo (einfacher Pigmentfleck oder Altersfleck) erschwert.\r\nÜber den genetischen Charakter von LMM (insbesondere hinsichtlich BRAF), aber auch solarer\r\nLentigo ist bisher nur wenig bekannt.\r\nDie BRAF V600E Mutation ist das am häufigsten detektierte onkologische Ereignis beim MM. In der\r\nvorliegenden Studie wird der Mutationsstatus von BRAF V600E in einem genau charakterisierten\r\nKollektiv aus FFPE LMM Gewebeproben analysiert. Dazu werden drei verschiedene, auf PCR\r\nbasierende, Methoden zur Mutationsanalyse optimiert und validiert. Die BRAF V600E\r\nMutationshäufigkeit wird in einem großem LMM Kollektiv bestimmt und ihre diagnostische und\r\nklinische Relevanz durch den Vergleich mit dem Mutationsstatus bei aktinischer Keratose und solarer\r\nLentigo evaluiert. Die Ergebnisse dieser Studie sollen zur Verbesserung der Diagnostik und\r\nDifferenzialdiagnostik und auch der Therapie des MM beitragen.", "en": "Malignant melanoma (MM) is considered the most aggressive form of skin cancers with a high\r\nmortality and often ineffective treatment, especially for metastasis. Prerequisites for the application\r\nof new and promising therapies are the precise diagnosis and the knowledge of the mutational status\r\nof the tumor.\r\nDiagnosis of Lentigo maligna melanoma (LMM), a special form of MM, is complicated since\r\npigmented actinic keratosis (in situ squamous cell carcinoma) and solar lentigo (senile freckle) can\r\nresemble LMM clinically and histopathologically. Only few data is available concerning the genetic\r\ncharacter of both LMM and solar lentigo (especially regarding BRAF).\r\nThe BRAF V600E mutation is the most frequent oncogenic event detected in MM. The study at hand\r\nwill analyze the BRAF V600E mutational status in a well characterized collective of FFPE LMM tissue\r\nsamples. For this purpose we will optimize and validate three different PCR based methods for\r\nmutational analysis. The incidence of the BRAF V600E mutation will be determined in a large LMM\r\ncollective and the diagnostic and clinical relevance of mutated BRAF will be evaluated by comparison\r\nwith that in pigmented actinic keratosis and solar lentigo. The results of this study should help to\r\nimprove the diagnostics means and contribute to advance therapy options of MM." }, "begin_planned": "2011-01-01T01:00:00+01:00", "begin_effective": "2011-01-01T01:00:00+01:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2012-06-30T02:00:00+02:00", "assignment": "2010-12-16T11:07:50+01:00", "program": 79, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": null, "manager": 50563, "contact": 50563, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2363-50229-12", "2363-50563-10", "2363-51066-12", "2363-51618-11" ] }, { "id": 1878, "title": { "de": "Anandamide/LPI signaling & function in endothelial cells", "en": "Anandamide/LPI signaling & function in endothelial cells" }, "short": "Anandamide/LPI", "url": null, "abstract": { "de": "Anandamide (ANA), also known as N-arachidonoylethanolamine, is a prominent substance of endocannabinoids, and exhibits multiple physiological functions in the brain, the immune system and the cardiovasculature. Although ANA is well known to contribute to human behavior, like eating and sleeping, and pain relief, evidence accumulated that ANA is an important vascular mediator that is released during tissue stress. LPI (lysophosphatidylinositol is another putatively important lipid mediator in the vessel wall.\r\nThe overall aim of this project is to explore ANA/LPI as important vascular mediators, to characterize their respective signal transduction, their interrelation and consequences to endothelial cell functions. In the end, our proposal aims to provide the scientific basis of consideration of the ANA/LPI system as therapeutic target for vascular-related medicine.", "en": "Anandamide (ANA), also known as N-arachidonoylethanolamine, is a prominent substance of endocannabinoids, and exhibits multiple physiological functions in the brain, the immune system and the cardiovasculature. Although ANA is well known to contribute to human behavior, like eating and sleeping, and pain relief, evidence accumulated that ANA is an important vascular mediator that is released during tissue stress. LPI (lysophosphatidylinositol is another putatively important lipid mediator in the vessel wall.\r\nThe overall aim of this project is to explore ANA/LPI as important vascular mediators, to characterize their respective signal transduction, their interrelation and consequences to endothelial cell functions. In the end, our proposal aims to provide the scientific basis of consideration of the ANA/LPI system as therapeutic target for vascular-related medicine." }, "begin_planned": "2009-07-01T02:00:00+02:00", "begin_effective": "2009-10-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2009-07-30T13:21:16+02:00", "program": 72, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 51860, "contact": 51860, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P21857", "ethics_committee": null, "edudract_number": null, "persons": [ "1878-50810-11", "1878-51860-10" ] }, { "id": 2789, "title": { "de": "Charakterisierung der pro-apoptotischen Wirkung des alpha1-adrenergen Antagonisten Prazosin auf humane Tumorzellen", "en": "Characterization of the pro-apoptotic action of the alpha1-adrenergic antagonist prazosin on malignant cells." }, "short": "Prazosin induzierte Apoptose", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-07-01T02:00:00+02:00", "begin_effective": "2011-07-01T02:00:00+02:00", "end_planned": "2012-07-01T02:00:00+02:00", "end_effective": "2012-07-01T02:00:00+02:00", "assignment": "2012-02-15T09:37:16+01:00", "program": null, "subprogram": null, "organization": 14014, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 530 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2765, "title": { "de": "Nanopartikel-Chancen und Risiken einer neuen Dimension", "en": "Nanoparticles- chances and risks of a new dimension " }, "short": "NANOPARTICLES CHANCES AND RISKS", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-08-01T02:00:00+02:00", "begin_effective": "2010-08-01T02:00:00+02:00", "end_planned": "2012-07-30T02:00:00+02:00", "end_effective": "2012-09-30T02:00:00+02:00", "assignment": "2012-01-23T16:27:35+01:00", "program": 58, "subprogram": null, "organization": 17230, "category": 10, "type": 10, "partner_function": 2, "manager": null, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2536, "title": { "de": "Chordome: erste Schritte in der Entwicklung neuer Therapieansätze", "en": "Chordomas: First steps towards a new therapy" }, "short": "Chordomas: New Therapy", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-08-01T02:00:00+02:00", "begin_effective": "2011-08-01T02:00:00+02:00", "end_planned": "2012-07-31T02:00:00+02:00", "end_effective": "2012-10-31T01:00:00+01:00", "assignment": "2011-07-18T14:17:06+02:00", "program": 79, "subprogram": null, "organization": 14052, "category": 10, "type": 10, "partner_function": 4, "manager": 53237, "contact": 53237, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2536-50696-12", "2536-61131-12", "2536-53237-10" ] }, { "id": 2292, "title": { "de": "Anreicherung und Charakterisierung von vermeintlichen Brustkrebsstammzellen", "en": "Enrichment and Characterization of putative Breast Cancer Stem Cells" }, "short": "ANREICHERUNG_BRUSTKREBSSTAMMZELLEN", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-08-01T02:00:00+02:00", "begin_effective": "2010-10-01T02:00:00+02:00", "end_planned": "2012-07-31T02:00:00+02:00", "end_effective": "2013-01-31T01:00:00+01:00", "assignment": "2010-09-06T17:13:23+02:00", "program": 79, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 50539, "contact": 50539, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2292-50539-10", "2292-50563-12", "2292-59188-11" ] }, { "id": 2537, "title": { "de": "Klinische Relevanz von Keimbahnpolymorphismen in Wnt/Notch/Hedgehog für Prognose bei Kolonkarzinomen", "en": "Clinical impact of germline polymorphisms in Wnt/Notch/Hedgehog for colon cancer outcome" }, "short": "GERMLINE POLYMORPH COLON CANCER", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-08-01T02:00:00+02:00", "begin_effective": "2011-11-01T01:00:00+01:00", "end_planned": "2012-07-31T02:00:00+02:00", "end_effective": "2012-10-31T01:00:00+01:00", "assignment": "2011-07-19T11:01:17+02:00", "program": 79, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 58814, "contact": 58814, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2537-58814-10" ] } ] }